A clinician warns that patients taking GLP-1 agonists like semaglutide or tirzepatide risk serious complications in cosmetic surgery if they don't disclose it. The drugs cause rapid fat loss, which can dissolve transferred fat in breast or facial procedures and accelerate aging. Anyone having facial work or fat transfer should stop these medications during surgery.
I put fat in you, or alternatively, I do something to your face, your breast, your body, and you're not telling me about a peptide like tirzepatide or semaglutide or whatever you're taking that's a GLP1 agonist, there are going to be consequences out of my control and potentially harming you, like making you age faster. If you're doing it to your face, making the fat transfer we did for your breast basically go away and disappear. Because these drugs, semiglutide, tirzepatide, the GLP1, they all work. And, and we don't, certainly in a case where we're doing a fat transfers, we don't want anybody taking that drug.
Absolutely not. No. That's not a great idea.
If I'm doing your face or doing your fat transfer, I don't want you on a GLP1 because you're going to burn, potentially facial fat. You're going to loosen up your face and your neck.
